London Business News | Londonlovesbusiness.com
2 months agoBusiness
Analyst sees over 100% upside potential in this pharma stock
Royalty Pharma PLC (NASDAQ: RPRX) is undervalued with over 100% upside potential according to Saqib Iqbal, a financial analyst. [ more ]